NCT01791543

Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia

Early Feasibility Study of Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 115 (actual)
• Sponsor: William Stevenson · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to assess the effectiveness and safety of a new device called an Intramural Needle Ablation Catheter (INA catheter). The INA catheter is used for locating and ablating ventricular arrhythmias that have failed standard radiofrequency ablation. This approach is desirable because some people have ventricular arrhythmias that originate deep within the heart muscle where it is not abolished by ablation with standard catheters. The investigators seek to determine whether the INA catheter can potentially help people who have ventricular arrhythmias that have failed standard radiofrequency ablation. The investigators also want to determine if it is likely to be safe, without excessive side effects.

Conditions

• Ventricular Tachycardia

Interventions

Type	Name	Description
DEVICE	Intramural Needle Ablation Catheter

Timeline

• Start date: 2016-09-01
• Primary completion: 2022-05-27
• Completion: 2022-05-27
• First posted: 2013-02-15
• Last updated: 2023-02-01
• Results posted: 2023-02-01

Locations

2 sites across 1 country: United States

Regulatory

• FDA-regulated device study